false
OasisLMS
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,it,ja,ko,pt,ru,es,sw,uz,vi
Login
Skip Navigation Links
EDU360 Home
IGCS Website
IGCS Profile
Education360 Information
Membership
FAQ
International Journal of Gynecological Cancer
Menu
EDU360 Home
IGCS Website
IGCS Profile
Education360 Information
Membership
FAQ
International Journal of Gynecological Cancer
Hamburger Menu
Catalog
Calendar
Help
ADVERTISEMENT
Search
select
10 miles
50 miles
100 miles
250 miles
500 miles
Search by map
Search Result for:
Education by Topic
Browse:
Education by Topic
Cervical Cancer (20)
Ovarian Cancer (24)
Uterine Cancer (26)
Vaginal & Vulvar Cancer (3)
Medical Oncology (38)
Surgical Education (16)
Palliative Care (4)
Pathology (6)
Radiation Oncology (8)
Nursing (8)
Literature - In The Know (2)
Early Career (7)
New Online Offerings
Surgical Films (8)
Medical Oncology (33)
Nursing (6)
Palliative Care (3)
Pathology (4)
Advocacy (1)
Radiation Oncology (4)
Certificate Programs
Evidence-Based Medicine (1)
Nursing (1)
Palliative Care (1)
Preinvasive Disease (1)
Translated Offerings
Spanish (9)
Portuguese (4)
Annual Global Meeting
2023 (2)
2022 (2)
2021 (1)
×
Sort By
select
Price: Low to High
Price: High to Low
Popularity
Most Recent
Oldest First
Alphabetical (A-Z)
Alphabetical (Z-A)
Most Relevant
Catalog Display Mode
Catalog Display Mode
Nursing ECHO Case Presentations
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Nursing ECHO Case Presentations
Free
Precision in Endometrial Cancer: Personalized Treatment Strategies for pMMR and dMMR Endometrial Cancer
This interactive 90-minute symposium will explore the evolving treatment landscape in endometrial cancer, focusing on the distinctions between dMMR and pMMR disease.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Precision in Endometrial Cancer: Personalized Treatment Strategies for pMMR and dMMR Endometrial Cancer
This interactive 90-minute symposium will explore the evolving treatment landscape in endometrial cancer, focusing on the distinctions between dMMR and pMMR disease.
Free
From Data to Practice: Integrating Key Phase III Results into Ovarian Cancer Management
Kathleen Moore details outcome measures from three major phase III trials—KEYNOTE-B96, ROSELLA, and MIRASOL—highlighting objective response rates, progression-free and overall survival, and key safety signals.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
From Data to Practice: Integrating Key Phase III Results into Ovarian Cancer Management
Kathleen Moore details outcome measures from three major phase III trials—KEYNOTE-B96, ROSELLA, and MIRASOL—highlighting objective response rates, progression-free and overall survival, and key safety signals.
Free
Surgical Film Library
Curated film collection reviewed by global surgical experts showcasing gynecologic oncology surgery procedures and techniques. Films provide practical learning through surgical demonstrations.
Library
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Surgical Film Library
Curated film collection reviewed by global surgical experts showcasing gynecologic oncology surgery procedures and techniques. Films provide practical learning through surgical demonstrations.
Free
IGCS ACCESS - Accelerating Cervical Cancer Elimination Strategies Symposium
The symposium brought together country representatives, clinicians, policymakers, and partners to advance coordinated national action across the full care continuum—HPV vaccination, screening, diagnosis, treatment, and palliative care—while addressing fragmented and siloed efforts.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
IGCS ACCESS - Accelerating Cervical Cancer Elimination Strategies Symposium
The symposium brought together country representatives, clinicians, policymakers, and partners to advance coordinated national action across the full care continuum—HPV vaccination, screening, diagnosis, treatment, and palliative care—while addressing fragmented and siloed efforts.
Free
Nursing and Allied Health Virtual Symposium
Hear from gynecologic oncology nursing and allied health professionals from around the world for an engaging, solutions-focused program that empowers the vital role of nursing in gynecologic cancer care.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Nursing and Allied Health Virtual Symposium
Hear from gynecologic oncology nursing and allied health professionals from around the world for an engaging, solutions-focused program that empowers the vital role of nursing in gynecologic cancer care.
Free
Redefining Platinum Sensitivity : Additional Treatment Considerations in a Changing Paradigm
Dr. Robert Coleman with moderation by Dr. Floor Backes and Dr. Wendel Naumman. Dr. Coleman explores the evolving treatment strategies for recurrent platinum-sensitive ovarian cancer, drawing on the latest clinical trial data and real-world outcomes.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Redefining Platinum Sensitivity : Additional Treatment Considerations in a Changing Paradigm
Dr. Robert Coleman with moderation by Dr. Floor Backes and Dr. Wendel Naumman. Dr. Coleman explores the evolving treatment strategies for recurrent platinum-sensitive ovarian cancer, drawing on the latest clinical trial data and real-world outcomes.
Free
Refining Molecular Classification and Personalizing Therapy in Endometrial Cancer
Presented during the IGCS and AGOI webinar Uterine Cancers in the Molecular Era: Changing Trends and Implications. Recorded on June 23, 2025.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Refining Molecular Classification and Personalizing Therapy in Endometrial Cancer
Presented during the IGCS and AGOI webinar Uterine Cancers in the Molecular Era: Changing Trends and Implications. Recorded on June 23, 2025.
Free
Is NSMP Truly a "Wastebox" Group? Identifying Homogeneous Subgroups Within This Heterogeneous Category
Presented during the IGCS and AGOI webinar Uterine Cancers in the Molecular Era: Changing Trends and Implications. Recorded on June 23, 2025.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Is NSMP Truly a "Wastebox" Group? Identifying Homogeneous Subgroups Within This Heterogeneous Category
Presented during the IGCS and AGOI webinar Uterine Cancers in the Molecular Era: Changing Trends and Implications. Recorded on June 23, 2025.
Free
Genetic Testing for Lynch Syndrome in Endometrial Cancer
In this special IGCS podcast episode, we spotlight the United Kingdom’s groundbreaking National Lynch Syndrome Project and its free, globally accessible e-learning modules that equip healthcare professionals with the knowledge and skills to implement genetic testing for Lynch syndrome in gynecologic oncology.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Genetic Testing for Lynch Syndrome in Endometrial Cancer
In this special IGCS podcast episode, we spotlight the United Kingdom’s groundbreaking National Lynch Syndrome Project and its free, globally accessible e-learning modules that equip healthcare professionals with the knowledge and skills to implement genetic testing for Lynch syndrome in gynecologic oncology.
Free
Uterine Cancers in the Molecular Era: Changing Trends and Implications
This 2-hour webinar will bring together international experts to explore evolving molecular insights, treatment trends, and clinical challenges in uterine cancer through lectures and a tumor board discussion.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Uterine Cancers in the Molecular Era: Changing Trends and Implications
This 2-hour webinar will bring together international experts to explore evolving molecular insights, treatment trends, and clinical challenges in uterine cancer through lectures and a tumor board discussion.
Free
Patient reported outcomes exploring quality of life in PROC and novel therapeutics: mirvetuximab in recurrent ovarian cancer
Discover how patient-reported outcomes highlight mirvetuximab’s ability to preserve quality of life while delivering meaningful clinical benefits for women with platinum-resistant ovarian cancer.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Patient reported outcomes exploring quality of life in PROC and novel therapeutics: mirvetuximab in recurrent ovarian cancer
Discover how patient-reported outcomes highlight mirvetuximab’s ability to preserve quality of life while delivering meaningful clinical benefits for women with platinum-resistant ovarian cancer.
Free
Journal Club:Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE)
Journal Club moderated by IGCS Radiation Oncology workgroup members Dr. Kathy Han (Canada) and Dr. Kevin Albuquerque (USA) featuring the article Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Journal Club:Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE)
Journal Club moderated by IGCS Radiation Oncology workgroup members Dr. Kathy Han (Canada) and Dr. Kevin Albuquerque (USA) featuring the article Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial.
Free
IGCS 2024 Endometrial Cancer Master Session
Held at the IGCS 2024 Annual Global Meeting in Dublin, Ireland on October 16, 2024.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
IGCS 2024 Endometrial Cancer Master Session
Held at the IGCS 2024 Annual Global Meeting in Dublin, Ireland on October 16, 2024.
Free
Journal Club: What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 24 months after premenopausal risk-reducing salpingo-ooph
Journal Club moderated by IGCS Palliative Care co-chairs Dr. Peter Grant (Australia) and Dr. Anisa Mburu (Kenya) featuring the article
What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 24 months after premenopausal risk-reducing salpingo-oophorectomy (RRSO).
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Journal Club: What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 24 months after premenopausal risk-reducing salpingo-ooph
Journal Club moderated by IGCS Palliative Care co-chairs Dr. Peter Grant (Australia) and Dr. Anisa Mburu (Kenya) featuring the article
What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 24 months after premenopausal risk-reducing salpingo-oophorectomy (RRSO).
Free
Journal Club - Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA
Discssion on article Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Journal Club - Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA
Discssion on article Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
Free
Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications
This course offers an in-depth exploration of personalized treatment approaches for endometrial cancers, focusing on proficient mismatch repair (pMMR), deficient mismatch repair (dMMR) diseases and molecular classification in the recurrent setting.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications
This course offers an in-depth exploration of personalized treatment approaches for endometrial cancers, focusing on proficient mismatch repair (pMMR), deficient mismatch repair (dMMR) diseases and molecular classification in the recurrent setting.
Free
Immunotherapy Toxicities Nursing Tumor Board
IGCS nursing workgroup held their first tumor board and discussed nursing care options for a cervical cancer patient experiencing immunotherapy toxicities.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Immunotherapy Toxicities Nursing Tumor Board
IGCS nursing workgroup held their first tumor board and discussed nursing care options for a cervical cancer patient experiencing immunotherapy toxicities.
Free
Journal Club: Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
Listen to a new Journal Club with PI Dr. Brian Slomovitz and moderator Dr. Leslie Randall as they discuss details on the New England Journal of Medicine published article Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Journal Club: Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
Listen to a new Journal Club with PI Dr. Brian Slomovitz and moderator Dr. Leslie Randall as they discuss details on the New England Journal of Medicine published article Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.
Free
Journal Club: The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial
Listen to a new Journal Club with lead author Dr. Angeles Alvarez Secord and moderator Dr. Robert Coleman as they discuss details on the recently published article The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial.
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Journal Club: The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial
Listen to a new Journal Club with lead author Dr. Angeles Alvarez Secord and moderator Dr. Robert Coleman as they discuss details on the recently published article The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial.
Free
Course
1
to
20
of
102
×